Chanazone 1g Oral Powder for Horses 5g Sachet
Chanazone 1g Oral Powder for Horses 5g Sachet is indicated for the treatment of musculoskeletal disorders in horses that are required to relieve pain and reduce related inflammation, eg, limping associated with osteoarthritic disorders, bursitis, laminitis, and soft tissue inflammation, especially where continued mobility is considered desirable. It is also important in reducing post-operative inflammation, myositis, and other soft tissue inflammations. It may be used as an antipyretic if considered appropriate, eg with viral respiratory tract infections.
Chanazone 1g Oral Powder for Horses 5g Sachet is recommended when administering to pregnant mares. Although no adverse effects of phenylbutazone on fetal maintenance or pregnancy have been reported in-field use, no definitive safety studies in mares have been conducted. The phytotoxic effects of phenylbutazone have been observed in experimental animal species at high doses. Ponies of this product are very sensitive to gastric ulcers, even at therapeutic doses (diarrhea, mouth ulcers, and hypoproteinemia can also be seen). If side effects occur, treatment should be discontinued and the veterinarian should be consulted. Phenylbutazone induces the activity of liver microsomal enzymes. There is a potential risk of increased renal toxicity following concomitant administration of aminoglycosides. Concomitant use of glucocorticoids, other NSAIDs or anticoagulants increases the side effects of phenylbutazone. The therapeutic efficacy of diuretics may be reduced when used in combination with phenylbutazone-containing formulations
- Do not use in animals with severe hypertonia.
- Do not use in animals suffering from thyroid disease.
- Do not use in animals with known hypersensitivity to the active substance.
- Do not use in animals with lesions in the intestinal mucosa, caused by parasitic infestations.
- Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastrointestinal ulceration or bleeding or where there is evidence of a blood dyscrasia.